Andreas Koulouris
About me
-Consultant, Medical Oncologist, Thoracic Oncology Center, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden
Karolinska University Hospital has been my professional home since 2021, where I serve as a Medical Consultant, deeply immersed in the intricacies of oncology and clinical research. My tenure here, complemented by a concurrent PhD candidacy, has honed my acumen in academic writing and cancer research, leading to multiple publications in esteemed journals.
The intersection of my clinical expertise and research allows for innovative contributions to the field of medicine, particularly in the understanding of brain metastases. Our team's collaborative efforts have unveiled novel microRNA profiles, prognostic scores for lung cancer patients with CNS involvement with a view to advancing the frontier of targeted cancer therapies and enriching the scientific community's resources to combat this challenging disease.
In navigating the complexities of cancer treatment and research, Sir William Osler's words resonate: "Medicine is a science of uncertainty and an art of probability..."DIPLOMAS AND TITLES:
2023 Recognition of specialist qualification in Sweden
2022 Specialty Certification in Medical Oncology (Hellas)
2021 2021 ESMO Examination Certificate (Awardee of the 2021 Best ESMO Examination with 94.8%)
2018 Diploma of the Hellenic Boards of Oncology Hellenic Society of Medical Oncology (HeSMO)
2015 ATLS (鈥淎dvanced Trauma Life Support鈥)
2014 School of Medicine, University of Athens, Hellas (Grade: Excellence 9, 10/10)
Research
1.
- Ph.D. Candidate at 探花精选. Medical research title: 鈥淓valuation of clinical and molecular variables and the development of prognostic tools in patients with advanced non-small cell lung cancer with brain metastases and targetable mutations.鈥 (Sweden, since 2024)
2. - Participation in the VEAP8964 study: 鈥淎n observational study to identify selection criteria for initiation of different first-line treatment options in NSCLC patients.鈥 (MSD, Sweden, 2022)
3. - Reviewer of the scientific journals: "Frontiers in Immunology", 鈥淛ournal of Clinical Medicine鈥 (JCM), 鈥淚nternational Journal of molecular sciences鈥 (IJMC), 鈥淛ournal of hepatocellular carcinoma鈥, 鈥淢edicina鈥, 鈥淔orum of Clinical Oncology鈥 (FCO), and 鈥淐linical Medicine Insights: Oncology鈥.
4. - Ph.D. candidate at the University of Crete. Medical research title: Correlations between detectable genetic mutations and the microbiota in plasma and stools with the recurrence risk of patients with colorectal carcinoma stage II &
- III. (Since 2019)
5. - Website and Social media executive on behalf of the HeSMO. (2019 - 2021)
6. - ESMO member, ESMO ID: 413683. (Since 2018)
7. - Participation in the REFINE post-approval trial at Hippokration University Hospital. (BAYER, 2018)
8. - Member of the Hellenic Group of Young Oncologists (HeGYO), a subgroup of HeSMO. (2016)
9. - Member of the Gastro-Intestinal Cancer Study Group (GIC-SG). (2016)
10. - Member of the Organization Committee for the 6th, 7th, and 8th Hellenic Student Oncology Meeting and coordinator of the workshops. (2012, 2013, 2014)
11. - Member of the Laboratory of Pharmacology, Faculty of Medicine, University of Athens. (2012)
Research interests include: lung cancer, colorectal cancer, hepatocellular cancer, brain metastatic disease, targeted treatment, immunotherapy, CAR T-cell therapy
Teaching
- Medical instructor for 探花精选 students in the course 鈥淐linical Medicine, specialization, surgery鈥, Karolinska University Hospital. (since 2021)
- Medical instructor for 探花精选 students of the University of Crete, University General Hospital of Heraklion. (2018-2021)
- Coordinating Doctor responsible for pre-med student education at Hippokration General Hospital, Atlantis project. (2017)
- Medical instructor for 探花精选 students of the University of Athens, Hippokration General Hospital. (2016-2018)
Articles
- Journal article: ANNALS OF ONCOLOGY. 2024;35:s858
- Journal article: CANCERS. 2024;16(10):1923
- Article: ESMO OPEN. 2023;8(6):102069
- Journal article: JOURNAL OF THORACIC ONCOLOGY. 2023;18(11):s638
- Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022;24(1):193
- Journal article: FORUM OF CLINICAL ONCOLOGY. 2022;13(3):3-14
- Article: ANNALS OF GASTROENTEROLOGY. 2022;35(1):88-94
- Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(4_suppl):171
- Article: CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY. 2014;92(1):78-84
All other publications
- Preprint: MEDRXIV. 2024
- Conference publication: JOURNAL OF THORACIC ONCOLOGY. 2023;18(11):s647
- Review: INTERNATIONAL JOURNAL OF CANCER. 2023;153(9):1556-1567
- Review: CANCERS. 2023;15(14):3700
- Conference publication: JOURNAL OF THORACIC ONCOLOGY. 2023;18(11):S638
- Conference publication: JOURNAL OF THORACIC ONCOLOGY. 2023;18(11):S647
- Review: CURRENT MEDICINAL CHEMISTRY. 2023;30(3):356-370
- Review: CANCERS. 2022;14(14):3337
- Conference publication: ANNALS OF ONCOLOGY. 2022;33:S306
- Review: CANCERS. 2021;13(14):3522
- Review: EXPERT REVIEW OF CLINICAL PHARMACOLOGY. 2021;14(6):651-659
- Review: TOXINS. 2021;13(2):149
- Review: JOURNAL OF HEPATOCELLULAR CARCINOMA. 2021;8:387-401
- Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(4)
- Other: ANNALS OF GASTROENTEROLOGY. 2020;33(1):95-97
Employments
- Consultant, Medical Oncologist, Department of Oncology-Pathology, Karolinska University Hospital, 2023-
- Phd Student, Department of Oncology-Pathology, 探花精选, 2024-2027